Why TPST stock attracts strong analyst attention - Free Stock Selection - beatles.ru
Yesterday • Google News
Tempest Therapeutics Inc (TPST)
US$ 7.76-3.6%
Price Chart
Key Statistics
Market Cap
$ 25.41M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
22.91K
52W High
$ 28.34
52W Low
$ 5.35
Dividend Yield
0.00%
Beta
-2.33
Technicals
50-Day MA
6.9339
200-Day MA
10.4886
52 Week High
28.34
52 Week Low
5.3495
About TPST
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
Employees
24
Headquarters
Brisbane, CA
CEO
Mr. Stephen R. Brady J.D., LLM
Latest News
Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews
2025-06-09 • Google News
TPST to Evaluate Strategic Options for Pipeline Studies, Stock Up - Zacks Investment Research
2025-04-10 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg